Insider trade

UiPath (PATH): CEO sold ~$747K

Daniel Dines, CEO at UiPath, sold ~$747K of UiPath shares.

~$747K
Approx. value · 45K sh @ $16.61
28.2M
Holds after · shares reported
Traded
Jan 12, 2026
Filed
Jan 13, 2026

What stands out in this filing

  • The sale was 0.2% of the shares this insider held before it; the filing reports 28,163,585 shares afterwards.
  • 45,000 shares at an average of $16.61 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 22, 2025InsiderOfficer sold ~$77K of PATH shares in the open market
  2. Dec 3, 2025Company filing · Form 8-K · ResultsReported its results
  3. Dec 5, 2025Insider · 2 peopleInsiders: 2 sales (~$1.3M)
  4. Dec 8, 2025InsiderCEO sold ~$865K of PATH shares in the open market
  5. Dec 9, 2025InsiderCEO sold ~$861K of PATH shares in the open market
  6. Dec 10, 2025InsiderCEO sold ~$837K of PATH shares in the open market
  7. Dec 11, 2025InsiderCEO sold ~$835K of PATH shares in the open market
  8. Dec 12, 2025InsiderCEO sold ~$806K of PATH shares in the open market
  9. Dec 15, 2025InsiderCEO sold ~$778K of PATH shares in the open market
  10. Dec 16, 2025InsiderCEO sold ~$732K of PATH shares in the open market
  11. Dec 17, 2025InsiderCEO sold ~$725K of PATH shares in the open market
  12. Dec 22, 2025InsiderCEO sold ~$742K of PATH shares in the open market
  13. Dec 23, 2025InsiderCEO sold ~$742K of PATH shares in the open market
  14. Dec 24, 2025InsiderCEO sold ~$761K of PATH shares in the open market
  15. Dec 26, 2025InsiderCEO sold ~$761K of PATH shares in the open market
  16. Dec 29, 2025InsiderCEO sold ~$740K of PATH shares in the open market
  17. Dec 30, 2025InsiderCEO sold ~$757K of PATH shares in the open market
  18. Dec 31, 2025InsiderCEO sold ~$745K of PATH shares in the open market
  19. Jan 2, 2026InsiderCEO sold ~$737K of PATH shares in the open market
  20. Jan 5, 2026Insider · 2 peopleInsiders: 2 sales (~$1.8M)
  21. Jan 6, 2026InsiderCEO sold ~$720K of PATH shares in the open market
  22. Jan 7, 2026InsiderCEO sold ~$779K of PATH shares in the open market
  23. Jan 8, 2026InsiderCEO sold ~$787K of PATH shares in the open market
  24. Jan 9, 2026InsiderCEO sold ~$773K of PATH shares in the open market
  25. Jan 12, 2026 · this disclosureInsiderCEO sold ~$747K of PATH shares in the open market

What came next

  1. Jan 13, 2026InsiderCEO sold ~$773K of PATH shares in the open market
  2. Jan 14, 2026InsiderCEO sold ~$706K of PATH shares in the open market
  3. Jan 15, 2026InsiderCEO sold ~$692K of PATH shares in the open market
  4. Jan 22, 2026InsiderCEO sold ~$676K of PATH shares in the open market
  5. Jan 23, 2026InsiderCEO sold ~$686K of PATH shares in the open market
  6. Jan 26, 2026InsiderCEO sold ~$676K of PATH shares in the open market
  7. Mar 5, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  8. Mar 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 24, 2026, the Compensation Committee of the Board of Directors (the “Board”) of UiPath, Inc. (the “Company”) appointed Raghavendra Malpani, the Company’s current Chief Technology Officer, as the Company’s Chief Product and Technology Officer, effective March 25, 2026 (the “Effective Date”).”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for UiPath

For UiPath, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PATH page.

Other recent filings by Daniel Dines, CEO and Chairman

The full history of Daniel Dines, CEO and Chairman is on the profile page.

How this filing works

Explore the data

Common questions

Which UiPath (PATH) insider traded, and how much?

Daniel Dines, CEO at UiPath, sold ~$747K of UiPath shares. 45K shares at $16.61.

When did it happen, and when was it made public?

Traded: Jan 12, 2026. Filed: Jan 13, 2026. That is 1 day between the two dates.

What stands out in this filing?

The sale was 0.2% of the shares this insider held before it; the filing reports 28,163,585 shares afterwards. 45,000 shares at an average of $16.61 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about UiPath recently?

For UiPath, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the PATH page.

Does this mean PATH stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at UiPath

Everything OQRO holds on this company is on its PATH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data